Julie Pelletier
About Julie Pelletier
Julie Pelletier is a Clinical Trial Manager at Bristol Myers Squibb in Saint-Laurent, Quebec, with extensive experience in clinical operations and quality assurance in the pharmaceutical industry.
Current Position at Bristol Myers Squibb
Julie Pelletier is currently employed as a Clinical Trial Manager at Bristol Myers Squibb in Saint-Laurent, Quebec. In this role, she is responsible for overseeing the intricacies of clinical trials, ensuring compliance with regulatory standards, and coordinating with various stakeholders to facilitate successful trial outcomes.
Previous Experience at Syneos Health
From 2020 to 2021, Julie Pelletier served as a Clinical Operations Lead at Syneos Health. During her tenure, she was involved in managing clinical operations and ensuring the smooth conduct of clinical trials. Her responsibilities likely included team management, project oversight, and strategic planning to optimize clinical operations.
Tenure at ethica CRO Inc.
Julie Pelletier worked at ethica CRO Inc. as a Senior Clinical Project Manager from 2018 to 2020. She was assigned to projects for Merck Canada Inc., where she specialized in managing clinical trials and ensuring adherence to regulatory guidelines and protocols. Her role involved comprehensive project management, from planning to execution, focusing on delivering high-quality results.
Experience with PRA Health Sciences
From 2012 to 2018, Julie Pelletier held the position of In-House CRA III at PRA Health Sciences, working on projects assigned to Merck Canada Inc. Over her six-year tenure, she gained extensive experience in clinical research administration, supporting project teams, and ensuring that clinical trial processes met both company and regulatory standards.
Educational Background
Julie Pelletier's academic foundation includes a B.Sc. in Biochemistry from the University of Quebec in Montreal, obtained between 1988 and 1991. She also earned an M.Sc. in Physiology from Université de Montréal. These qualifications have provided her with a robust understanding of biochemical and physiological principles, underpinning her expertise in clinical trial management and pharmaceutical research.